Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Depei Wu

Showing results (11-20 of 579) with videos related to

Pageof 58
Sort By:
Molecular Medicine Reports|January 26, 2021
Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemiaGuoqiang Lin, Yanming Zhang, Lei Yu, et al.
Frontiers of Medicine|September 24, 2022
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)Suning Chen, Weili Zhao, Jianyong Li, et al.
Leukemia & Lymphoma|April 18, 2009
Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acidHaiwen Huang, Depei Wu, Jinxiang Fu, et al.
Carcinogenesis|March 3, 2021
LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphomaYan Huang, Yuanyuan Lin, Xiangxiang Song, et al.
Indian Journal of Cancer|May 8, 2019
Efficacy of high-dose cytarabine and aclarubicin in combination with G-CSF regimen compared to intermediate/high-dose cytarabine and standard-dose cytarabine induction regimen for non-remission acute myeloid leukemiaMeiqing Lei, Limin Liu, Zhiming Wang, et al.
Pediatric Blood & Cancer|April 14, 2011
Relapse of aplastic anemia responsive to sirolimus combined with cyclosporineGuangsheng He, Xiang Zhang, Depei Wu, et al.
International Journal of Clinical and Experimental Pathology|July 21, 2015
Bortezomib inhibits bone marrow-derived dendritic cellsYing Wang, Yong Liang, Yanming Zhang, et al.
Transplantation and Cellular Therapy|May 14, 2021
Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisYiyu Xie, Jay Parekh, Zaixiang Tang, et al.
Chinese Medical Journal|December 31, 2025
Chinese Society of Hematology clinical practice guidelines for the comprehensive management of allogeneic hematopoietic stem cell transplantation in patients with severe aplastic anemiaLanping Xu, Xi Zhang, Depei Wu, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 7, 2024
Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid LeukemiaRuixue Ma, Yunju Ma, Qingya Cui, et al.
Pageof 58

Showing results (11-20 of 579) with videos related to

Sort By:
Pageof 58
Molecular Medicine Reports|January 26, 2021
Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemiaGuoqiang Lin, Yanming Zhang, Lei Yu, et al.
Frontiers of Medicine|September 24, 2022
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)Suning Chen, Weili Zhao, Jianyong Li, et al.
Leukemia & Lymphoma|April 18, 2009
Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acidHaiwen Huang, Depei Wu, Jinxiang Fu, et al.
Carcinogenesis|March 3, 2021
LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphomaYan Huang, Yuanyuan Lin, Xiangxiang Song, et al.
Indian Journal of Cancer|May 8, 2019
Efficacy of high-dose cytarabine and aclarubicin in combination with G-CSF regimen compared to intermediate/high-dose cytarabine and standard-dose cytarabine induction regimen for non-remission acute myeloid leukemiaMeiqing Lei, Limin Liu, Zhiming Wang, et al.
Pediatric Blood & Cancer|April 14, 2011
Relapse of aplastic anemia responsive to sirolimus combined with cyclosporineGuangsheng He, Xiang Zhang, Depei Wu, et al.
International Journal of Clinical and Experimental Pathology|July 21, 2015
Bortezomib inhibits bone marrow-derived dendritic cellsYing Wang, Yong Liang, Yanming Zhang, et al.
Transplantation and Cellular Therapy|May 14, 2021
Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisYiyu Xie, Jay Parekh, Zaixiang Tang, et al.
Chinese Medical Journal|December 31, 2025
Chinese Society of Hematology clinical practice guidelines for the comprehensive management of allogeneic hematopoietic stem cell transplantation in patients with severe aplastic anemiaLanping Xu, Xi Zhang, Depei Wu, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 7, 2024
Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid LeukemiaRuixue Ma, Yunju Ma, Qingya Cui, et al.
Pageof 58